Unknown OBSERVATIONAL NCT04232891

Early Detection of Relapses in Stage IV Colorectal Cancer Patients (REDCLOUD)

Early Detection of Relapses in Stage IV Colorectal Cancer Patients: REDCLOUD (REsidual Disease, Colorectal Cancer, Liquid biOpsy Detection)

Sponsor: Fondazione del Piemonte per l'Oncologia

Conditions Metastatic Colorectal Cancer

Interventions liquid biopsy

Updated 7 times since 2020 Last updated: Jan 16, 2020 Started: Nov 18, 2019 Primary completion: Jun 30, 2021 Completion: Jun 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04232891, this observational or N/A phase trial focuses on Metastatic Colorectal Cancer and remains ongoing. Sponsored by Fondazione del Piemonte per l'Oncologia, it has been updated 7 times since 2019, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Aug 2023 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Dec 2021 — Aug 2023 [monthly]

Recruiting
Jan 2021 — Dec 2021 [monthly]

Recruiting

▶ Show 2 earlier versions

Nov 2020 — Jan 2021 [monthly]

Recruiting
Feb 2020 — Nov 2020 [monthly]

Recruiting

First recorded

Nov 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fondazione del Piemonte per l'Oncologia

Data source: Fondazione del Piemonte per l'Oncologia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Candiolo, Italy
• Torino, Italy